Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Kiwi3

GYPHQ

Tschabrun

spec. Interesting to note that he took a job with GGN rather than SGN knowing...

October 2, 2012

GYPHQ

RE: What have they accomplished

ruth. Patience will be rewarded. The shareholders here are patient and...

October 1, 2012

GYPHQ

RE: RE: RE: Kiwi's last post

mylar. Bail money should move to a GGN investment. I watched another...

September 30, 2012

GYPHQ

RE: Kiwi's last post

mylar. Just been travelling. Being a shareholder and therefore having a...

September 30, 2012

GYPHQ

RE: RE: RE: RE: RE: RE: RE: qe3 passed

I am going to have to learn about chart analysis. One of our group who is a...

September 13, 2012

GYPHQ

RE: RE: RE: RE: RE: RE: RE: qe3 passed

Your comments are very wise. Tom got creamed by Waterton and Peter. The same...

September 13, 2012

GYPHQ

RE: RE: RE: RE: RE: qe3 passed

It takes a published strategic plan then everyone can see the road map. It is...

September 13, 2012

GYPHQ

RE: RE: qe3 passed

They will be ok as they have the assets. I am not sure about the production...

September 13, 2012

GYPHQ

RE: RE: Trading...

Let us buy. The dead cat has been thrown in by management. It is really dead....

September 12, 2012

GYPHQ

RE: RE: RE: RE: Gryphon

Greyman. Hole number FF-229-.44 oz/t including 1.02 oz/t , CBO .23 oz/t...

September 12, 2012

GYPHQ

RE: RE: RE: RE: Gryphon

I think I will stay in denial and keep on buying- 2.3 million oz Au at $ 16.5...

September 12, 2012

GYPHQ

RE: RE: RE: RE: Gryphon

I think the key here is "able to communicate" and probably just do...

September 12, 2012

GYPHQ

RE: RE: Gryphon

All indications are that they have a lot of positives to be communicating and...

September 12, 2012

GYPHQ

Gryphon

Still looking but have not found anything as close in value. Just basic value...

September 11, 2012

SGGDF

RE: RE: RE: Action

I should improve my spelling (tooth) as well as my investing skills as others...

September 8, 2012

GYPHQ

RE: RE: RE: RE: RE: Denver Gold Forum Sept 9 thru

Improvements have definately been made but we still have not seen a plan so...

September 8, 2012

GYPHQ

RE: RE: RE: Denver Gold Forum Sept 9 thru 12

You are right as at the last show there was no one at the GGN booth. Our...

September 7, 2012

SGGDF

RE: RE: Action

I actually bought a whole lot more. I also believe in Santa , ...

September 7, 2012

GYPHQ

RE: RE: RE: Denver Gold Forum Sept 9 thru 12

I believe Mr O'Neil lives in Denver and commutes.

September 7, 2012

GYPHQ

Meeting Today...

Thanks Belgie. I also think the amendement was a good idea but I would like...

September 6, 2012

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals Inc. C.AGN

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed ... view more »